Inhaled Nitric Oxide (iNO) and Inhaled Epoprostenol (iPGI2) Use in Cardiothoracic Surgical Patients: Is there Sufficient Evidence for Evidence-Based Recommendations?
Publication
, Journal Article
Rao, V; Ghadimi, K; Keeyapaj, W; Parsons, CA; Cheung, AT
Published in: J Cardiothorac Vasc Anesth
June 2018
Duke Scholars
Published In
J Cardiothorac Vasc Anesth
DOI
EISSN
1532-8422
Publication Date
June 2018
Volume
32
Issue
3
Start / End Page
1452 / 1457
Location
United States
Related Subject Headings
- Randomized Controlled Trials as Topic
- Nitric Oxide
- Humans
- Evidence-Based Medicine
- Epoprostenol
- Endothelium-Dependent Relaxing Factors
- Cost-Benefit Analysis
- Cardiac Surgical Procedures
- Antihypertensive Agents
- Anesthesiology
Citation
APA
Chicago
ICMJE
MLA
NLM
Rao, V., Ghadimi, K., Keeyapaj, W., Parsons, C. A., & Cheung, A. T. (2018). Inhaled Nitric Oxide (iNO) and Inhaled Epoprostenol (iPGI2) Use in Cardiothoracic Surgical Patients: Is there Sufficient Evidence for Evidence-Based Recommendations? J Cardiothorac Vasc Anesth, 32(3), 1452–1457. https://doi.org/10.1053/j.jvca.2017.12.014
Rao, Vidya, Kamrouz Ghadimi, Worasak Keeyapaj, Cody A. Parsons, and Albert T. Cheung. “Inhaled Nitric Oxide (iNO) and Inhaled Epoprostenol (iPGI2) Use in Cardiothoracic Surgical Patients: Is there Sufficient Evidence for Evidence-Based Recommendations?” J Cardiothorac Vasc Anesth 32, no. 3 (June 2018): 1452–57. https://doi.org/10.1053/j.jvca.2017.12.014.
Rao V, Ghadimi K, Keeyapaj W, Parsons CA, Cheung AT. Inhaled Nitric Oxide (iNO) and Inhaled Epoprostenol (iPGI2) Use in Cardiothoracic Surgical Patients: Is there Sufficient Evidence for Evidence-Based Recommendations? J Cardiothorac Vasc Anesth. 2018 Jun;32(3):1452–7.
Rao, Vidya, et al. “Inhaled Nitric Oxide (iNO) and Inhaled Epoprostenol (iPGI2) Use in Cardiothoracic Surgical Patients: Is there Sufficient Evidence for Evidence-Based Recommendations?” J Cardiothorac Vasc Anesth, vol. 32, no. 3, June 2018, pp. 1452–57. Pubmed, doi:10.1053/j.jvca.2017.12.014.
Rao V, Ghadimi K, Keeyapaj W, Parsons CA, Cheung AT. Inhaled Nitric Oxide (iNO) and Inhaled Epoprostenol (iPGI2) Use in Cardiothoracic Surgical Patients: Is there Sufficient Evidence for Evidence-Based Recommendations? J Cardiothorac Vasc Anesth. 2018 Jun;32(3):1452–1457.
Published In
J Cardiothorac Vasc Anesth
DOI
EISSN
1532-8422
Publication Date
June 2018
Volume
32
Issue
3
Start / End Page
1452 / 1457
Location
United States
Related Subject Headings
- Randomized Controlled Trials as Topic
- Nitric Oxide
- Humans
- Evidence-Based Medicine
- Epoprostenol
- Endothelium-Dependent Relaxing Factors
- Cost-Benefit Analysis
- Cardiac Surgical Procedures
- Antihypertensive Agents
- Anesthesiology